1-800-TEMPLE-MED

News Line

Page size:
select
 507 items in 51 pages
 
Page size:
select
 507 items in 51 pages

Temple Lung Center Director Reports Continued Positive Results for Study Examining Minimally Invasive Treatment of Severe Emphysema

Twelve months in, EMPROVE shows patients with the Spiration® Valve System have statistical and clinically meaningful improvements in lung function, target lobe volume reduction, shortness of breath and quality-of-life parameters. read more »

Dr. Cecelia Schmalbach Appointed The Inaugural David Myers, MD Professor and Chair in Otolaryngology-Head and Neck Surgery at the Lewis Katz School of Medicine at Temple University

This newly-endowed Chair will support in perpetuity the department’s excellence and innovation in clinical care, research, and medical training. read more »

Temple Scientists Identify Genetic Variants Almost Exclusive to African Americans That Predict Poor Outcomes in Dilated Cardiomyopathy Heart Disease

Genetic testing is a powerful diagnostic tool that is increasingly being used for the diagnosis of dilated cardiomyopathy, a disease in which the heart becomes enlarged, making it difficult to pump blood. read more »

Temple Performs Nation’s First Non-Surgical Lung Volume Reduction for Patient with Severe Emphysema

Temple also recently became the first U.S. site to begin training U.S. physicians on the care and management of emphysema patients who may receive the Zephyr® Endobronchial Valve read more »

Dr. Thomas Fekete Appointed Chair of Medicine at Temple

Thomas Fekete, MD, has been appointed Chair of Medicine at Temple University Hospital (TUH) and at the Lewis Katz School of Medicine at Temple University (LKSOM) effective July 15, 2018. Dr. Fekete has served as Interim Chair of Medicine since November 2017. read more »

Temple-Led Research Calls into Question the Effectiveness of Inferior Vena Cava Filter Use in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis

Findings Suggest Practice Offered No In-Hospital Mortality Benefit and Was Associated with Increased Procedure-Related Hematomas, Increased Length of Stay and Higher Charges read more »

Temple University Hospital Offering First FDA-Approved Minimally Invasive Bronchoscopic Treatment for Emphysema

FDA Grants Pre-Market Approval to Zephyr Endobronchial Valve after Review of Temple-Led International Clinical Trial of this Novel Device read more »

New Research Provides Expanded Insights into the Brain’s Response to Opioids and the Search for a New Class of Painkillers with Fewer Side Effects

Researchers from the Lewis Katz School of Medicine at Temple University contributed to a study led by a team at the Max Planck Institute of Biochemistry. read more »

Temple Scientists Eradicate Cancer Cells Through Dual Targeting of DNA Repair Mechanisms

New research by scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) may help eradicate cancer cells. read more »

Temple Researchers Successfully Reverse Cognitive Impairments in Mice with Dementia

Researchers at the Lewis Katz School of Medicine show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer's disease – can be reversed by a drug. read more »